Pfizer COVID-19 vaccine trial shows 100% efficacy for ages 12-15
Tests of the Pfizer-BioNTech COVID-19 vaccine for ages 12-15 have showed 100% efficacy and robust antibody responses, the company announced on Wednesday.
Tests of the Pfizer-BioNTech COVID-19 vaccine for ages 12-15 have showed 100% efficacy and robust antibody responses, the company announced on Wednesday.